Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
186M
-
Number of holders
-
125
-
Total 13F shares, excl. options
-
66.4M
-
Shares change
-
+9.08M
-
Total reported value, excl. options
-
$3.05B
-
Value change
-
+$427M
-
Put/Call ratio
-
0.05
-
Number of buys
-
78
-
Number of sells
-
-41
-
Price
-
$45.88
Significant Holders of Revolution Medicines, Inc. - Common Stock (RVMD) as of Q1 2021
148 filings reported holding RVMD - Revolution Medicines, Inc. - Common Stock as of Q1 2021.
Revolution Medicines, Inc. - Common Stock (RVMD) has 125 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 66.4M shares
of 186M outstanding shares and own 35.75% of the company stock.
Largest 10 shareholders include FMR LLC (10.8M shares), TRV GP III, LLC (5.52M shares), VANGUARD GROUP INC (4.85M shares), WELLINGTON MANAGEMENT GROUP LLP (3.92M shares), BlackRock Inc. (3.83M shares), The Column Group LLC (3.58M shares), BOXER CAPITAL, LLC (3.48M shares), BVF INC/IL (2.94M shares), Cormorant Asset Management, LP (2.53M shares), and TRV GP II, LLC (1.91M shares).
This table shows the top 125 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.